Brandon J Harder (Brandon Harder)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 3

Top Topics

Ulcerative Colitis

Immune Response

Top Venues

Proteomics. Clinical applications

Pharmacology research & perspectives

Genentech Inc

Univeristy of Washington (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Genentech Inc Dec 01 2014

United States

Senior Scientific Researcher :: OMNI Biomarker Development

Amgen Inc Jan 20 2010 - Oct 26 2014

United States

Senior Associate Scientist :: Clinical Immunology

Zymogenetics Inc Sep 17 2000 - Dec 17 2009

United States

Senior Associate Scientist :: Immunology and Inflammation

Education History

Univeristy of Washington Sep 20 1993 - Jun 15 1997

United States

BSC :: Microbiology

University of Washington Sep 20 1993 - Jun 15 1997

United States

BSC :: Biochemistry

Publications

Brandon J Harder, Annemarie N Lekkerkerker, Ellen P Casavant, Jason A Hackney, Allen Nguyen, Jacqueline M McBride, William Rodney Mathews, Veronica G Anania
Comprehensive profiling of the human fecal proteome from IBD patients with DIA-MS enables evaluation of disease-relevant proteins. Proteomics. Clinical applications (2024)
Frank Wagner, John C Mansfield, Annemarie N Lekkerkerker, Yehong Wang, Mary Keir, Ajit Dash, Brandon Butcher, Brandon J Harder, Luz D Orozco, Jordan S Mar, Hao Chen, Michael E Rothenberg
Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis. Gut (2023)
Donna W Lee, Shelly Zhong, Rama Pai, Julie Rae, Siddharth Sukumaran, Eric G Stefanich, Jeff Lutman, Estelle Doudement, Xiaoting Wang, Brandon J Harder, Annemarie N Lekkerkerker, Ann Herman, Wenjun Ouyang, Dimitry M Danilenko
Nonclinical safety assessment of a human interleukin-22FC IG fusion protein demonstrates in vitro to in vivo and cross-species translatability. Pharmacology research & perspectives 6 (6) (2018)